Status:
RECRUITING
Intravenous Hydromorphone for the Treatment of Acute Pain
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborating Sponsors:
Yichang Humanwell Pharmaceutical Co., Ltd., China
Conditions:
Acute Chest Pain
Eligibility:
All Genders
18-64 years
Phase:
PHASE1
PHASE2
Brief Summary
To observe the efficacy and safety of hydromorphone in the treatment of acute chest pain, and to explore the potential advantages of hydromorphone for analgesia in patients with acute chest pain, so a...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age 18-64 years old;
- Gender is not limited;
- Patients with acute chest pain, with the time from pain onset to visit the doctor ≤ 24 days;
- Severe pain that requires the use of opioids to control as determined by emergency physicians;
- Obtain informed consent from the patient or family members.
- Exclusion criteria:
- Known allergy to hydromorphone or morphine;
- Systolic blood pressure \<100 mmHg, oxygen saturation \<95%, pulse less than 60 beats/min;
- Use of acetaminophen or nonsteroidal anti-inflammatory drugs in the past 8 hours;
- Chronic pain, defined as pain lasting for more than 12 weeks;
- Delirium, alcohol withdrawal symptoms or other drug intoxication;
- Pregnant or lactating women;
- Patients with mental or neurological diseases, cognitive and consciousness disorders and inability to express correctly;
- Participating in any other research at the same time;
- Factors that increase the risk of participating in the study (life-threatening chest pain patients who require rapid diagnosis or treatment intervention, such as resuscitation status, excluding chest pain caused by myocardial infarction), who are judged by the researchers to be unsuitable for inclusion in the study.
Exclusion
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06949059
Start Date
January 1 2025
End Date
December 31 2027
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China, 210008